Exits
Chinese heparin maker in historic IPO for Goldman
Shenzhen Hepalink Pharmaceutical Co, Ltd, is debuting on the Shenzhen Stock Exchange, selling up to 40.1 million shares at RMB148 ($21.68) each, the most expensive IPO price for a Chinese stock to date.
TPG sees OK for SDB exit to Ping An
TPG Capital has had the way cleared for its exit from its pioneering PRC financial services investment Shenzhen Development Bank (SDB), as the China Securities Regulatory Commission (CSRC) gave Ping An Insurance Group approval to issue shares in exchange...
CVCI part exits JBF to parent
CVC International has reportedly sold roughly two thirds of its remaining stake in JBF Global Singapore, a polyester chip maker, to its Indian parent, JBF Industries, for some $60 million.
Dragon Capital sells Vietnam mining JV to TPG investee
Tiberon Minerals, owned by Vietnam-based investment firm Dragon Capital, will sell a control stake in the Nui Phao Mining Joint Venture Company, a tungsten mining project in development, to Masan Group, backed by TPG Capital.
Shenzhen turns pig parts into gold?
Goldman Sachs seniors still trembling from their grilling before the US Senate and the news of a criminal probe by federal prosecutors could take comfort in at least one win for the reeling banking giant last week – the stellar IPO of Shenzhen Hepalink...
Nomura Principal sells Misawa to industry peer
Nomura Principal Finance Co., Ltd., a wholly-owned subsidiary of Nomura Holdings, Inc., has said it will sell its entire stake in Misawa Home Co., a Tokyo-based housebuilding company, to Toyota Home Co., a housing unit of Toyota Motor Co.
Goldman due 200x return in China pharma IPO
With the Shenzhen IPO of little-known Chinese pharmaceutical company Shenzhen Hepalink Pharmaceutical, Goldman Sachs will see an almost certain 200-fold profit on its original $5 million investment.
Kotak contemplates multiple exits
Kotak Investment Advisors is considering exits for up to five of its portfolio companies, including Bharat Fritz Werner, BVG India, Home Solutions Retail, Metahelix Life Sciences, and SIRO Clinpharm, according to Indian reports.
Sequoia hits gold with Manappuram
Sequoia Capital has exited its 11% stake in Manappuram General Finance and Leasing, a non-bank financial company specializing in loans based on gold.
Hopu, Temasek investee Iron Mining gets $250 million from China Life
Hopu Investment Management and Temasek Holdings investee Iron Mining International has secured a $250 million pre-IPO commitment from leading PRC insurer China Life.
Advent exits SCADAgroup to Schneider
Australian mid-market private equity firm Advent Private Capital has announced the exit of its investment in waste and water systems integration business SCADAgroup to Schneider Electric, for around A$200 million ($185 million).
Advantage exits Daiei to DB, others
Advantage Partners has sold its entire remaining 11.7% voting stake in Japanese retailer Daiei for around $106 million to Deutsche Securities, an arm of Deutsche Bank, which is holding the stake temporarily for client trading purposes.
NPS may join on KEB
Korea's National Pension Service may participate in the acquisition of Korea Exchange Bank from Lone Star Funds, according to Korean reports.
Deal drivers across Asia Pacific
As three-figure deals on both the entry and exit side – and in the case of some secondary transactions, both – start to rack up across the region, 2010 is already looking like a bustling year for Asia Pacific.
Carlyle may part exit Claris
The Carlyle Group is likely to exit at least part of its almost 14% stake in Indian drugs firm and IPO candidate Claris Lifesciences, according to reports.
SC Asia sells DLF stake for $696 million
Private equity investor SC Asia has sold most of its stake in DLF Assets, an Indian real estate management and investment firm, to its parent DLF Ltd., for some $696 million.
OB refinancing, IPO on cards
Several banks have submitted unsolicited proposals for the refinancing of the $1 billion five-year leverage loan that underwrote Kohlberg Kravis Roberts and Affinity Equity Partners' $1.8 billion buyout of Korea's Oriental Brewery in 2009, amid talk of...
MBK exiting CNS
MBK Partners has hired Morgan Stanley to advise on an exit for its Taiwanese cable investee China Network Systems, which could fetch up to $2 billion.
PEP, CHAMP in Loscam second round?
CHAMP Private Equity and Pacific Equity Partners have been instanced as potential buyers in a second bidding round for the putative A$500-700 million ($460-640 million) sale of Affinity Equity Partners Australian investee Loscam.
Bessemer, Olympus investee Orient Green Power plans IPO
Bessemer Venture Partners and Olympus Capital investee Orient Green Power Company, a renewable energy developer, has filed with SEBI in India for an IPO, seeking to raise over $200 million.
ATO delay ominous for Oz PE
The Australian Taxation Office has delayed two rulings on profits from private equity transactions until end May, indicative of a harder stance on the issue, according to some observers.
TPG joins Bain on Lilliput
TPG Capital's growth capital arm is joining Bain Capital in its investment in Delhi-based children's clothing business Lilliput Kidswear.
ANZ targeting KEB?
Lone Star Funds' protracted exit from controversial investee Korea Exchange Bank (KEB) has taken a fresh twist with reports that Australia and New Zealand Banking Group (ANZ) is planning a $4 billion bid for its controlling stake in the asset.
Trikona exiting Fortis
Trikona Trinity Capital, a listed private equity firm floated on London's AIM board, is reportedly exiting its pre-IPO investment in India's Fortis Healthcare in stages.